Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -22.20 is 91% above its 5-year average of -249.07, near the high end of its 5-year range (-746.00–-22.20).
18.98% above its 12-month average of -27.40.
Reported quarterly EPS; no daily interpolation. Q1 FY2026 (2026-03-31): -2.40.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 36 comparable quarters.
EARNINGS PER SHARE (EPS)
-22.20
EARNINGS PER SHARE (EPS) AVG TTM
-27.40
EARNINGS PER SHARE (EPS) AVG 3Y
-44.30
EARNINGS PER SHARE (EPS) AVG 5Y
-249.07
EARNINGS PER SHARE (EPS) AVG 10Y
-68049.31
EARNINGS PER SHARE (EPS) AVG 15Y
-118667.31
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.98%
CURRENT VS 3Y AVG
+49.89%
CURRENT VS 5Y AVG
+91.09%
CURRENT VS 10Y AVG
+99.97%
CURRENT VS 15Y AVG
+99.98%
CURRENT VS 20Y AVG
N/A
BioRestorative Therapies, Inc.
Market Cap
$3.14M
Earnings Per Share (EPS)
-22.20
TTM Avg
-27.40
3Y Avg
-44.30
5Y Avg
-249.07
Market Cap
$3.07M
Earnings Per Share (EPS)
-1.43
TTM Avg
-2.52
3Y Avg
-2.09
5Y Avg
-1.32
Market Cap
$3.21M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
Market Cap
$3.25M
Earnings Per Share (EPS)
N/A
TTM Avg
-12.74
3Y Avg
-17.52
5Y Avg
-18.26
Market Cap
$3.28M
Earnings Per Share (EPS)
N/A
TTM Avg
-1108.98
3Y Avg
-1045.55
5Y Avg
-1171.01
Market Cap
$3.30M
Earnings Per Share (EPS)
-14.40
TTM Avg
-19.95
3Y Avg
-16.43
5Y Avg
-17.45
Market Cap
$2.94M
Earnings Per Share (EPS)
-7.00
TTM Avg
-55.82
3Y Avg
-2440.85
5Y Avg
-6532.68
Market Cap
$2.86M
Earnings Per Share (EPS)
-6.76
TTM Avg
-8.05
3Y Avg
-9.85
5Y Avg
-9.67
Market Cap
$3.49M
Earnings Per Share (EPS)
-0.45
TTM Avg
-1.48
3Y Avg
-5.05
5Y Avg
-8.12
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | $3.14M | -22.20 | -27.40 | -44.30 | -249.07 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | -1.43 | -2.52 | -2.09 | -1.32 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | -11.70 | -48.19 | -238.41 | -340.02 |
| MBody AI Ltd. (MBAI)vs › | $3.25M | N/A | -12.74 | -17.52 | -18.26 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | N/A | -1108.98 | -1045.55 | -1171.01 |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -14.40 | -19.95 | -16.43 | -17.45 |
| Revelation Biosciences, Inc. (REVB)vs › | $2.94M | -7.00 | -55.82 | -2440.85 | -6532.68 |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | -6.76 | -8.05 | -9.85 | -9.67 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
Trailing EPS (TTM)
$-22.20
Forward EPS (Est.)
$-6.60
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -31.60 |
| 2024-12-31 | -23.20 |
| 2023-12-31 | -49.40 |
| 2022-12-31 | -73.00 |
| 2021-12-31 | -746.00 |
| 2020-12-31 | -571.20 |
| 2019-12-31 | -52601.60 |
| 2018-12-31 | -131246.40 |
| 2017-12-31 | -139200.00 |
| 2016-12-31 | -168000.00 |
| 2015-12-31 | -256000.00 |
| 2014-12-31 | -352000.00 |
| 2013-12-31 | -560000.00 |
| 2012-12-31 | -800000.00 |
| 2011-12-31 | -800000.00 |
| 2010-12-31 | -800.00 |
